drugset / Trial / NCT01317225

Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone

NCT01317225 ↗

Phase 3 Unknown 80 enrolled Saint Thomas Hospital, Panama
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine if the use of 250 mg of intramuscular progesterone biweekly can reduce the incidence of preterm labor in patients with an episode of threatened preterm labor during the current pregnancy.

Timeline

Start
2011-06
Primary completion
2015-07
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject 17α Hydroxyprogesterone Caproate Unknown 250 mg Intramuscular

Indications